EXPERIMENTALLY-INDUCED MYCOPLASMA-PNEUMONIAE PNEUMONIA IN CHIMPANZEES

被引:10
|
作者
BARILE, MF
GRABOWSKI, MW
KAPATAISZOUMBOS, K
BROWN, B
HU, PC
CHANDLER, DKF
机构
[1] PRIMATE RES INST,HOLLOMAN AFB,NM 88330
[2] UNIV N CAROLINA,SCH MED,DEPT PEDIAT,CHAPEL HILL,NC 27514
关键词
MYCOPLASMA-PNEUMONIAE; CHIMPANZEE; PRIMARY ATYPICAL PNEUMONIA; PATHOGENESIS; IMMUNOLOGICAL RESPONSE;
D O I
10.1006/mpat.1993.1075
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Eight chimpanzees were examined. Two served as negative control and six inoculated with Mycoplasma pneumoniae became colonized. Colonization persisted for 28-68, 16-50 and 21 days with an average duration of 47, 32.5 and 21 days in the oropharyngeal, tracheal and lung tissues, respectively. Mycoplasma titers ranged from 108 to 101 color-changing units per specimen during the course of the infections. Seroconversion occurred within 12-15 days and peak antibody titers ranged from 1.256 to 1.1024 and developed between days 28 and 48 post-inoculation. Positive cold agglutinin titers were detected between 12 to 15 days and peak titers ranged from 1:80 to 1:640. Significant increases in sIgA and IgG immunoglobulin antibody levels were detected in lung lavage fluids. Unlike the many other experimentally infected animals examined, chimpanzees infected with M. pneumoniae had positive X-ray findings, developed cold agglutinins and showed overt signs of disease. These signs include persistent cough, low grade fever, rhinitis, oropharyngitis, diarrhea, and loss of appetite. Peak severity of disease corresponded with peak lung colonization, and the detection of cold agglutinins and positive X-ray findings. The microbiological, serological and clinical aspects of pneumonia induced in chimpanzees was similar to naturally occurring primary atypical pneumonia in humans. © 1993 Academic Press.
引用
收藏
页码:243 / 253
页数:11
相关论文
共 50 条
  • [1] EXPERIMENTALLY-INDUCED SEPTIC ARTHRITIS IN CHIMPANZEES INFECTED WITH MYCOPLASMA-HOMINIS, MYCOPLASMA-PNEUMONIAE, AND UREAPLASMA-UREALYTICUM
    BARILE, MF
    KAPATAISZOUMBOS, K
    SNOY, P
    GRABOWSKI, MW
    SNELLER, M
    MILLER, L
    CHANDLER, DKF
    CLINICAL INFECTIOUS DISEASES, 1994, 18 (05) : 694 - 703
  • [2] MYCOPLASMA-PNEUMONIAE PNEUMONIA
    CLYDE, WA
    MILITARY MEDICINE, 1971, 136 (01) : 20 - &
  • [3] MYCOPLASMA-PNEUMONIAE PNEUMONIA
    MANSEL, JK
    ROSENOW, EC
    SMITH, TF
    MARTIN, JW
    CHEST, 1989, 95 (03) : 639 - 646
  • [4] MORE ON MYCOPLASMA-PNEUMONIAE PNEUMONIA
    CONE, LA
    JODOIN, VD
    MOJARAD, M
    SOTO, D
    WESTERN JOURNAL OF MEDICINE, 1995, 163 (02): : 180 - 180
  • [5] SEVERE MYCOPLASMA-PNEUMONIAE PNEUMONIA
    GUMP, DW
    HAWLEY, HB
    RESPIRATION, 1976, 33 (06) : 475 - 486
  • [6] FREQUENCY OF MYCOPLASMA-PNEUMONIAE PNEUMONIA
    FOY, HM
    ALLAN, ID
    LANCET, 1982, 1 (8268): : 392 - 392
  • [7] MYCOPLASMA-PNEUMONIAE PNEUMONIA AND PANCREATITIS
    VELASCO, FP
    REVISTA CLINICA ESPANOLA, 1990, 187 (07): : 368 - 368
  • [8] FULMINANT MYCOPLASMA-PNEUMONIAE PNEUMONIA
    CHAN, ED
    WELSH, CH
    WESTERN JOURNAL OF MEDICINE, 1995, 162 (02): : 133 - 142
  • [9] MYCOPLASMA-PNEUMONIAE PNEUMONIA TREATMENT WITH DOXYCYCLINE
    HERRELL, WE
    CLINICAL MEDICINE, 1971, 78 (04) : 14 - &
  • [10] SPECTRUM OF MYCOPLASMA-PNEUMONIAE PNEUMONIA IN CHILDREN
    GAMBERT, C
    WERNER, E
    DEKERDANET, M
    MONGINET, F
    BRUEL, H
    JEZEQUEL, C
    PEDIATRIE, 1993, 48 (03): : 241 - 247